EverSource Wealth Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$140K Sell
2,229
-443
-17% -$30.9K ﹤0.01% 1243
2025
Q4
$177K Buy
2,672
+1,804
+208% +$117K 0.01% 1001
2025
Q3
$58.4K Sell
868
-268
-24% -$21.2K ﹤0.01% 1589
2025
Q2
$99.2K Sell
1,136
-86
-7% -$6.74K ﹤0.01% 1210
2025
Q1
$83.5K Buy
1,222
+525
+75% +$42.8K ﹤0.01% 985
2024
Q4
$54.2K Buy
697
+27
+4% +$2K ﹤0.01% 1154
2024
Q3
$44.9K Sell
670
-394
-37% -$32.4K ﹤0.01% 1117
2024
Q2
$72.2K Sell
1,064
-24
-2% -$3.03K ﹤0.01% 926
2024
Q1
$139K Buy
1,088
+17
+2% +$2.14K 0.01% 599
2023
Q4
$133K Buy
1,071
+98
+10% +$10K 0.01% 546
2023
Q3
$90.7K Sell
973
-5
-0.5% -$564 0.01% 604
2023
Q2
$126K Buy
978
+35
+4% +$4.23K 0.01% 501
2023
Q1
$110K Sell
943
-3
-0.3% -$336 0.01% 512
2022
Q4
$107K Buy
946
+16
+2% +$1.76K 0.02% 488
2022
Q3
$75K Buy
930
+845
+994% +$71.6K 0.02% 516
2022
Q2
$7K Buy
85
+17
+25% +$1.55K ﹤0.01% 1149
2022
Q1
$9K Sell
68
-68
-50% -$7.44K ﹤0.01% 1007
2021
Q4
$18K Buy
+136
New +$19.5K 0.01% 728

Other funds holding DXCM

EverSource Wealth Advisors's DXCM Position: Q1 2026 in Review

EverSource Wealth Advisors reduced its DexCom (DXCM) stake by 17% in Q1 2026, selling an estimated $30.9K and leaving 2,229 shares worth $140K. The position accounts for ﹤0.01% of the portfolio, ranked #1243.

EverSource Wealth Advisors first reported a position in DXCM in Q4 2021 and has held it in 18 quarters since. The position peaked at $177K in Q4 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • EverSource Wealth Advisors held 2,229 shares of DexCom worth $140K as of Q1 2026.
  • EverSource Wealth Advisors sold 443 DexCom shares in Q1 2026, an estimated $30.9K.
  • DexCom made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q1 2026, its #1243 holding.
  • EverSource Wealth Advisors first reported a position in DexCom in Q4 2021 and has held it in 18 quarters since.
  • EverSource Wealth Advisors's DexCom position peaked at $177K in Q4 2025.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on EverSource Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.